Bellshill, United Kingdom · Founded 2017 · Privately Held (backing)
Developer of microbiome-modulating drugs designed to restore health and prevent bacterial infections. EnteroBiotix is based in Bellshill, United Kingdom and was founded in 2017. Its last reported valuation was $66.8 million in Mar 2024. It has raised $94.2 million across 6 recorded rounds; the latest was a $5.3 million early-stage round in Mar 2026.
Last reported valuation
$66.8M
Oct 2026
Priced at
—
Total raised
$94.2M
Last round
Early Stage VC
Mar 2026
Cap table — not yet on record
EnteroBiotix's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of EnteroBiotix with a free account
·The complete investor list: 20 names
·Watch EnteroBiotix: the Monday email on marks, rounds and moves
